Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0183 | ||||
Gene Name | SLC25A22 | ||||
Protein Name | Mitochondrial glutamate carrier 1 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | EIEE3; GC-1; GC1; Glutamate/H(+) symporter 1; NET44; SLC25A22; Solute carrier family 25 member 22 | ||||
DT Family | Mitochondrial Carrier (MC) Family ; | ||||
Tissue Specificity | Highly expressed in most tissues. | ||||
Function | This transporter involved in the transport of glutamate across the inner mitochondrial membrane. | ||||
Endogenous Substrate(s) | H+ | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
L-glutamic acid
|
Approved | Drug Info | Schizophrenia | 6A20 | [1] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 24 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
4-chloro-phenylalanine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Alanine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Alpha-ketoglutarate | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Arginine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Asparagine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Aspartate | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Citrate | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Citrulline | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Fumarate | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Glutamate | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Glutamine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Isocitrate | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Malate | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
N1,N12-diacetylspermine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
N1-acetylputrescine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
N1-acetylspermidine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
N1-acetylspermine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Ornithine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Oxaloacetate | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Proline | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Putrescine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Spermidine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Spermine | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
Succinate | EM Info | Identified using SLC25A22 knockdown KRAS-mutant DLD1 cells | [2] | ||
References | |||||
1 | Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet. 2005 Feb;76(2):334-9. | ||||
2 | LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer. Oncotarget. 2017 Sep 20;8(60):101333-101344. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.